| Similar Articles |
 |
Bio-IT World February 2006 Kevin Davies |
Curtain Opens on Life Sciences Expo Highlights of the upcoming Life Sciences Conference + Expo: Keynotes... Conference Tracks... Speakers... Educational workshops... etc.  |
Bio-IT World March 2006 |
Special Show Preview: It's Showtime! Highlights of the upcoming fifth annual Bio IT World conference: Decoding the Genome... The Six-Figure Sequence... E-Clinical Futures... etc.  |
Bio-IT World September 2006 Kevin Davies |
Pfizer's Global Survey of Pharmacological Space The pharma blends knowledge, computational chemistry and research informatics to build a unified database. Gathering all the data in one place offered greater control for indexing and data retrieval and management, enabling Pfizer scientists to perform global mapping.  |
Bio-IT World August 2005 |
Best Practices 2005 Winners Winners of the Best Practices awards include an innovative drug safety monitoring system, an integrated genomics gateway, and a genotyping pipeline.  |
Bio-IT World March 8, 2005 |
Coming Attractions Ten reasons why you can't miss the Bio*IT World Conference + Expo in May. Headlines and Legends... Advances in Genomic Medicine... IT Solutions for Drug Discovery... etc.  |
Bio-IT World February 18, 2004 |
It's Showtime! The 2004 Bio*IT World Conference + Expo promises to be our most exceptional event yet.  |
Bio-IT World March 2006 |
Bio-IT World Bio-IT 50 The 50 companies profiled here have driven and continue to drive the future of biomedical research and drug discovery: Accelrys... Affymetrix.. Apple... Becton Dickinson... BlueArc... 454 Life Sciences... etc.  |
Bio-IT World September 2005 Kevin Davies |
Fantastic 454: DNA Sequencing Pyrotechnics In an exciting advance for DNA sequencing technology, a research team at 454 Life Sciences Corp. has essentially sequenced and assembled a bacterial genome sequence based on a mere 4-hour run on the company's proprietary instrument.  |
Bio-IT World August 2005 |
Project Summaries Summaries of candidates for Bio-IT World's "Best Practices 2005" projects.  |
Bio-IT World Dec 2006/Jan 2007 |
Resolute in the New Year Industry leaders in areas from pharmacogenetics to cheminformatics found 2006 to be a year of important steps forward, but looked with even more anticipation to 2007: Allen D. Roses, SVP, Pharmacogenetics GlaxoSmithKline... etc.  |
Bio-IT World August 18, 2004 John Russell |
Special Report: 2004: A Best Practices Odyssey Grand Prize Winners: Drug Discovery & Development: Iconix Pharmaceuticals... IT Infrastructure & Informatics: Baylor College of Medicine, Department of Molecular and Cellular Biology Core Lab... etc.  |
Bio-IT World June 12, 2002 Beth Schachter |
Informatics Moves to the Head of the Class The race is on to increase the quantity and quality of bio-IT training programs as government and academia bet the need will be great. Will the job market back up that bet?  |
Bio-IT World February 18, 2004 |
A Perfect 10? Oracle's new 10g database comes complete with bells and whistles that only industrial-strength, compute-savvy life scientists will appreciate.  |
Bio-IT World November 12, 2002 Michael Goldman |
A Virtual Pharmacopeia Computational modeling of disease pathways, organs --- even patients --- could transform drug discovery. Does salvation exist in silico?  |
Bio-IT World January 21, 2005 |
Defining 'Integrative Genomics' Five experts from academia and industry discuss the burgeoning field of integrative genomics.  |
Bio-IT World April 2006 Kevin Davies |
Microsoft Forges BioIT Alliance The software giant's fledgling alliance aims to bring together companies from a cross-section of the industry -- from biotech and Big Pharma to equipment manufacturers and software developers -- to collaborate on technology that will speed drug discovery.  |
Bio-IT World August 13, 2002 Russell & Dodge |
Necessary Liaisons: Making Standards Work Caroline Kovac, IBM Corp.'s general manager for life sciences, talks about the need for standards and her take on the troubled informatics world.  |
Bio-IT World August 2005 Kevin Davies |
Special Report: Bio-IT World Best Practices 2005 Each year, the Best Practices awards program spotlights examples of the most outstanding innovations, technologies, and practices in the drug discovery pipeline.  |
Bio-IT World April 15, 2003 Malorye Branca |
Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease?  |
Bio-IT World November 12, 2002 James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success.  |
Bio-IT World November 2005 |
Bridges and Boundaries in Drug Discovery Research Good communication, blurring cultural boundaries, and strong project governance may be as, if not more, important as sweeping technology solutions when it comes to converging discovery and IT and expediting drug development.  |
Bio-IT World September 16, 2004 Kevin Davies |
Computing the Genome Boston University's Charles DeLisi explains his involvement with the human genome project and why he has recently turned his attention to systems biology and an AIDS vaccine.  |
Bio-IT World January 21, 2005 Salvatore Salamone |
A Prescription for Information-Based Medicine TurboWorx president and CEO Jeff Augen not only combines computational and biology expertise, but also has a clear vision of how to advance life science discovery.  |
Bio-IT World November 2006 Kevin Davies |
Building a Bridge Over Pharma with IT More than 100 enthusiastic delegates bridging the full breadth of the drug development pipeline gathered recently for the second annual Bridging Pharma and IT conference. Here are some highlights.  |
Bio-IT World October 9, 2002 Kevin Davies |
Cracking the 'Druggable Genome' How many potential drug targets are encoded in the human genome? It is a crucial question for every biopharma business.  |
Bio-IT World December 10, 2002 |
Craig Venter Unvarnished (part II) The former Celera CEO covers privacy, ESTs, and his new research institutes.  |
Bio-IT World April 2007 Kevin Davies |
Eddy Wins 2007 Franklin Award Sean Eddy, a principal scientist at the new Howard Hughes Medical Institute Janelia Farm Research Campus in Northern Virginia, has won the 2007 Benjamin Franklin Award in the Life Sciences.  |
Bio-IT World September 2006 John Russell |
Informatics Cornucopia Predictive Informatics, the hopeful title of a session at last month's Drug Discovery Technology & Development World Congress, remains an enticing but mostly elusive goal. Asked what systems biology would look in five years and what will constitute success, panelists offered the following.  |
Bio-IT World June 2006 Kevin Davies |
David Shaw: No Hedging on Future of Computer Simulations The computational scientist who founded the world's largest alternative investment firm says he is two years away from building a new breed of computer that could be a major breakthrough in structural biology -- simulating the process of protein folding and protein-drug interactions.  |
Bio-IT World July 14, 2004 Davies & Russell |
The Sweet Hereafter Novartis' stunning new research home in a former candy factory is but one ingredient in a bold new recipe for success that embraces leadership, culture, science, and technology.  |
Bio-IT World November 14, 2003 Julia Boguslavsky |
Genome Center in a Box Scientists at 454 Life Sciences developed an integrated end-to-end instrument that performs hundreds of thousands of reactions in parallel -- from sample preparation, amplification, and sequencing to data storage and bioinformatics.  |
Bio-IT World February 10, 2003 Salvatore Salamone |
Made in Manhattan A talk with the new head of the Computational Biology Center at Memorial Sloan-Kettering.  |
Bio-IT World July 11, 2002 Malorye Branca |
Deep Sequence Diving Like sailors of old, genomic data miners dream of discovering riches and fame. Given the recent improvements in analytics -- and a little more time -- they just might succeed.  |
Bio-IT World February 2006 |
News Blast Franklin Award... Improved Sensitivity... Discovery Tag Team... NIH Screening Begins...  |
Bio-IT World June 15, 2003 Kevin Davies |
The Overly Bold and the Beautiful For many (who really ought to know better), the temptation to fetishize DNA is all but irresistible.  |
Bio-IT World July 11, 2002 Mike Fitzgerald |
Funding the Future Investor G. Steven Burrill, CEO of Burrill & Company, helps biotech companies fulfill their potential. He talked recently about his view of the bio-IT field.  |
Bio-IT World January 13, 2003 John Dodge |
Talent Fuels Drug Pipeline in Swiss Time The functional genomics group has emerged as a critical link in the drug discovery chain at Novartis Pharmaceuticals Corp. While it employs a multidisciplinary approach to drug discovery, the four-year-old group's goals could not be simpler: Find novel drug targets.  |
Bio-IT World April 2006 Kevin Davies |
Bio*IT World's New Beginning Cambridge Healthtech Institute, along with its new acquisition of Bio*IT World, under the new name of Cambridge Bio Collaborative will become the key information and conference resource for the industry.  |
Industrial Physicist Jennifer Ouellette |
Bioinformatics moves into the mainstream An explosion of data is being tamed with new systems  |
Bio-IT World August 15, 2005 John Russell |
Reasons for Optimism Submissions to the 2005 Bio-IT World Best Practices Awards Program included a description of a systems of hieroglyphic representations of proteins, a platform for integrative genomics, and a number of entries that saved man hours by utilizing client management tools.  |
CIO October 15, 2001 Stephanie Overby |
Drug Companies on speed The marriage of IT and medical research may be just what traditional pharmaceutical companies need to survive in an increasingly competitive field. Learn how IT is bringing the pharmaceutical industry into the information age...  |
Bio-IT World April 2007 |
News Briefs Molecular Medicine's "Best of Show"... Dissolving Assets... Combined Forces...  |
Bio-IT World April 2006 John Russell |
Pfizer's Pursuit of Technology Can this $50-billion-plus, 115,000-employee behemoth succeed where other pharma giants have failed and successfully institutionalize the effort to find and develop critical new technology? Should it even try?  |
| Knowledge@Wharton |
A New Approach to Valuing Biotech Stocks Enormous swings in biotechnology stock prices during the last few weeks show how difficult it is for investors to value biotech companies. It's important to understand the invisible potential locked up in the organizational structure of biotechnology companies...  |
Bio-IT World January 21, 2005 |
Best Practices 2005: Strut Your Stuff Organizations are invited to strut their stuff for Bio*IT World's annual awards program.  |
Bio-IT World June 2006 John Russell |
Gilna to Captain CAMERA Later this summer researchers will gain access to version 0.5 of CAMERA (the Community Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis) a platform replete with a wealth of data, analysis tools, and high-speed computational infrastructure.  |
Bio-IT World September 2005 Kevin Davies |
Bringing Good Things to Informatics In interview with Nick Giannasi, Head of Informatics for GE Healthcare's Bio-Sciences division on how the company is shedding light on data integration in discovery and clinical trials.  |
IEEE Spectrum March 2013 Susan Hassler |
Genome to Go It's already possible to have your own genome sequenced. But personalized medicine based on sequencing still has a way to go  |
Bio-IT World November 19, 2004 John Russell |
GSAC Rolls On Genome Sequencing and Analysis Conference rolls on... Stephen Quake discusses research on single-molecule DNA sequencing by synthesis... A photocleavable fluorescent nucleotide for DNA sequencing and analysis...  |
Bio-IT World December 15, 2003 Zachary Zimmerman |
Learning the Language of Systems Biology Geneticist par excellence David Botstein talks about his philosophy, science, his mission for integrative science, and what he deems a success for systems biology.  |